# FDA 483 - ONESOURCE SPECIALTY PHARMA LIMITED - September 01, 2022

Source: https://www.globalkeysolutions.net/records/483/onesource-specialty-pharma-limited/0447af6f-e010-4802-b86c-e4eaa5a0deb4

> FDA 483 for ONESOURCE SPECIALTY PHARMA LIMITED on September 01, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ONESOURCE SPECIALTY PHARMA LIMITED
- Inspection Date: 2022-09-01
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-03-28](https://www.globalkeysolutions.net/records/483/onesource-specialty-pharma-limited/9bd2bb77-3188-4c4f-bf85-189380be4b13)
- [483 - 2022-07-19](https://www.globalkeysolutions.net/records/483/onesource-specialty-pharma-limited/c9aaee26-f7fa-4479-8f81-982b962ef535)
- [483 - 2022-07-19](https://www.globalkeysolutions.net/records/483/onesource-specialty-pharma-limited/5efb1033-0a8c-463a-9bb2-7a807f107075)
- [483 - 2022-07-19](https://www.globalkeysolutions.net/records/483/onesource-specialty-pharma-limited/e292d2c2-10b3-442e-b3b9-e20011133854)

## Related Officers

- [Joshua J. Silvestri](https://www.globalkeysolutions.net/people/joshua-j-silvestri/433e29b3-ce5f-44d2-9984-7a6cb61e1824)

Company: https://www.globalkeysolutions.net/companies/onesource-specialty-pharma-limited/cc051245-e85e-4a66-99ba-4bd9ab31a869

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd